Patent Application
20220381764
This present invention relates generally to the field of methods for approximating a volume and/or detecting blood in a fluid, particularly adapted for an electronic system. The field of approximating blood in a fluid, including systems that may be implemented employing a uniform resource locator (URL) that corresponds to a webpage or other web resource, are also related to the present invention. The invention also generally relates to the field of tracking fluid loss. The invention provides for new and useful systems and methods for estimating blood volume in fluids from a subject during a medical procedure.
During surgery, blood, saline, and in some cases, small tissue is evacuated from a subject's body, and collected in a collection container. Typically, this evacuation process is accompanied by suction. The components in the collection canister include at least some volume of blood in most cases. However, the volume of blood included is difficult to assess with any degree of accuracy. Blood loss assessment is critical to the health of the subject, but currently is assessed by only crude techniques associated with the counting of saline units employed during the surgical procedure by the attending health care professional/anesthesiologist. At the conclusion of the surgery, typically the anesthesiologist will estimate the amount of blood lost by determining what volume of saline was used during the surgery overall, and then subtracting this saline volume from the total volume of mixed material collected in the collection canister(s).
Blood is composed of RBCs, and RBCs require a significant amount of time (over 3-6 hours) to settle out of a blood/fluid mixture collected at the time of surgery. Apart from the significant time required to provide even a reading of settled RBC volume, it has been found that the settled RBC volume does not provide an adequate approximation of blood volume for assessing blood needs. Current techniques for estimating blood loss are fraught with challenges, including human error (counting “used” saline bags, accounting for residual saline) and serious time constraints associated with conventional blood-containing fluid analysis.
Failure to accurately approximate blood loss during a surgical event results in a number of potentially serious health complications to the patient, as well as increased medical costs. For example, underestimation of blood loss can result in failure to provide a needed blood transfusion to the subject. This in turn results in the subject, in many cases, becoming anemic, requiring extended hospitalized to stabilize the patient and/or even death. An over estimation of blood loss may result in unnecessary blood transfusions and/or other unnecessary medical interventions, as well as in waste of blood units. Such may also cause increased risk of disease transmission (for example HIV, hepatitis).
The medical arts remain in need of improved techniques and materials to accurately estimate blood loss. Methods for more accurately monitoring and approximating blood volume in a fluid are needed. Fluid collection products suitable for providing a more accurate blood volume approximation are also needed, as will serve to reduce medical costs associated with unnecessary medical treatments and interventions that occur as a result.
Inaccurate estimation of fluid loss (e.g., blood) from a patient, such as during a medical procedure, may put the patient's health at risk. For example, accurate measurement of blood lost by a mother after childbirth may help quickly diagnose a life-threatening instance of postpartum hemorrhage, which is a leading cause of maternal mortality. Underestimation of patient blood loss may lead to delayed resuscitation and transfusion, increased risk of infections, tissue death, or even patient death, such as in the event of hemorrhage.
Overestimation of patient blood loss may result in the unnecessary transfusion, contributing to potential wasteful blood resource management, and potentially dangerous effects on a subject. These events contribute to high ended operating and medical costs for hospitals, clinics, and other medical facilities.
Underestimation of blood volume in a fluid, such as blood from fluids lost from a subject during surgery, have been associated with inadequate patient care/death, and billions of dollars associated with extended hospitalization and recouperation of such inadequately treated patients.
Systems have been proposed for monitoring blood loss from a subject that involve a before and an after weight measurement of multiple surgical materials, such as gauss, sponges, and surgical textile material. Spent/used materials such as these are collected during a surgical or other health care related procedure, such as during childbirth. The amount of blood lost by a subject is determined by estimating the weight of blood lost. The weight of blood lost is determined by weighing the material before use (without blood) and weighing the materials after use (used/blood saturated materials), the difference between these weights providing an estimated weight of the blood that was contained in the used/blood saturated materials. The estimated weight of the blood in the materials is then used to estimate an approximate volume of blood that correlates with the estimated weight of the blood from the materials. Thus, an approximate volume of blood from a medical event is extrapolated from the approximate weight of blood in used/blood saturated materials collected during a medical event.
In an electronic method, blood measurement is provided by a user transmitting an electronic pixilated image of a selected field of liquid material (blood) within a container, to a central computing processor. The image from the selected field pixilated image is then processed by the central computing processor to extrapolate an approximate total volume of blood in a container, based on the pixel density of the selected image from the container. The pixel density of the selected image is observed to be a function of the concentration of hemoglobin in the fluid.
Neither of the above techniques provide for a direct measurement of blood. Instead, they rely on extrapolated values from secondary, non-direct data sources, and involve numerous complicated steps and equipment. As a result, the methods suffer from a clinically unacceptable margin of error. Multiple steps and other complexities associated with weighing and re-weighing of materials, and user error/inaccuracy in recording before/after weights, result in unreliable blood assessments. The electronic system for blood volume assessment via selected image-transmission relies on second-hand digital image transmission and extrapolation, is dependent on hemoglobin content, and is too costly for large scale use. Inaccuracy and/or unreliability in blood volume assessment render these current available techniques impractical.
Improved, simpler, less cost restrictive, and more reliably accurate systems for blood volume estimation and blood loss monitoring are needed in the medical arts.
In a general and overall sense, the present invention provides materials, devices and methods for more reliably and accurately approximating blood volume in a liquid, especially in a liquid collected during a surgical procedure. These methods are provided in an electronically implemented system that is cost effective, reliable, and readily implemented in conventional hospital and health care delivery environments.
Within this disclosure, it should be understood that the characterization of red blood cell (RBC) volume separated from a fluid containing blood plasma, saline or any other fluid (e.g., urine), does not mean an absolute or total separation, but instead an approximation of the stable sedimentation of RBCs in the fluid. RBC sedimentation is to be assessed at room temperature, and relates to the settlement of RBCs in a sample liquid by gravity (no centrifugation).
Methods of Approximating Blood Volume in a Liquid. In one aspect, methods for measuring blood loss from a mammal, such as a human or veterinary animal, are provided.
The method in some embodiments comprises providing a liquid in a container and permitting the RBC's within the liquid to sediment (without centrifugation) so as to provide a visual RBC sedimentation volume. While settled RBC sedimentation volume does not equate to blood volume in a liquid, the RBC sedimentation volume is used to approximate blood volume in the liquid.
In some embodiments, the method employs a RBC sedimentation volume observed in the presence of a RBC flocculant, the aspect ratio of the collection device and an average hematocrit, to provide a visually ascertainable approximation of blood volume in the liquid. The visually ascertainable approximation of blood volume in a liquid/fluid containing or possibly containing blood using the present devices and methods may be achieved in less than an hour, and as quickly as within 15-30 minutes, using the techniques described herein. The very short time frame facilitated for providing RBC sedimentation in the presence of an RBC flocculant, and the consequent visual assessment of approximate blood volume, provides significant advantages in maintaining the well-being of the patient, as well as significant resource savings to the health care provider.
In some embodiments, the methods may employ the use of a material that will reduce the time required for red blood cells to settle and/or sediment out of a fluid. The period of time in which red blood cells from a fluid will form a stable sedimentation level may be reduced by providing a material to the fluid and/or a collection container that serves to associate with the red blood cells. Such materials include red blood cell flocculants. Any variety of red blood cell flocculants may be used in the practice of the present methods and techniques, for example, PolyDADMAC and polyaluminum chloride (PAC). Anything that is designated a “cationic flocculant” will provide for sedimentation of red blood cells through a similar chemical mechanism. These red blood cell flocculants may be referred to generally as flocculants.
A method for detecting presence of blood in a liquid is also provided. Such methods may be used to screen and/or test a material (such as food materials, water, pharmaceuticals, etc.) for the presence of blood, blood contamination and/or quality control. By way of example, a sample from a material to be tested would be processed according to any of the methods described herein, such as in the presence of a flocculant, and examined for the presence of RBC sedimentation. RBC sedimentation would indicate the presence of blood in the sample material.
Blood Indicator Panel. In some aspects, a Blood Indicator Panel (BIP) having defined demarcations calibrated to correlate with an approximation of blood volume in a fluid containing or suspected to contain blood is provided, as well as methods for preparing a BIP specific for blood from a particular mammal (human/non-human). Specific collection devices associated with the defined BIP are also presented.
The BIP may be used in conjunction with any conventional fluid collection devise and/or collection bag, in the presence or absence of an RBC flocculant, to provide an approximation of blood volume in a fluid. The BIP employs a calculation that incorporates an estimated average hematocrit of the animal and/or blood type being assessed as well as a collection device packed RBC packing ratio (determined for the collection device/container). A BIP is specifically provided for veterinary (equine, bovine, canine, feline) human and human uses (adult, infant). Reference to the BIP provides an efficient manner (without need for performing individual calculation) for estimating blood volume in a mixed fluid/liquid by cross-reference to settled RBC volume on a collection device. In some embodiments, the BIP may be used without conventional volumetric measures, and include only the calibrated blood volume markings for identification of blood volume in a liquid as a function of the sedimented red blood cell volume observed. In such cases, the average hematocrit, type of blood and packing ratio of the device have been used to pre-calibrate a series of blood volume measurement markings on a BIP, so as to provide approximated blood volume measures with or without reference to a sedimented and/or settled RBC level.
RBC Flocculants and RBC Flocculation in a Fluid/Liquid. In one aspect, particular flocculants are identified that are suitable for flocculating RBCs, and thereby facilitate the sedimentation of RBCs by gravity more quickly than in the absence of a red blood cell flocculant. Combined with a biological fluid, such as the aspirate or other surgical run-off collected during a surgical or other medical procedure episodes, the RBC flocculant will facilitate the rapid sedimentation of RBC's within a mixed fluid, such as within about 5 minutes, about 15 minutes, or from about 15 to about 30 minutes, compared to several hours that would otherwise be required for RBCs in a fluid to settle in the absence of a RBC flocculant.
As used in the description of the present invention, flocculation is defined as the coalescence or formation of clusters of RBCs, within a fluid comprising blood or potentially comprising blood. The methods may therefore be used to detect blood contamination, as well as to quantify an amount of blood in a material by providing for the detection of RBCs in the material and approximate blood volume according to the methods disclosed herein.
Fluids potentially comprising blood include saline, surgical aspirate, urine, bile, other biological waste materials, saliva, tissue preparations, digestive fluids, cerebral fluids, lymph, peritoneal fluid, amniotic fluid, and any mixture or combination of these. In this regard, virtually any moiety or chemical agent that is capable of promoting the coalescence of RBCs within less than about 30 minutes at room temperature to provide a stable settled RBC level, is considered useful as a RBC flocculant for purposes of providing the present devices and for use in the present methods. It is envisioned that virtually any moiety or chemical entity that may impart a positive surface charge to a negatively charged RBC would be useful to promote a more rapid coalescence, or flocculation, of RBC's together sufficient to enhance the speed of RBC sedimentation as part of the present devices and methods.
RBCs present in a fluid containing blood become bound to each other in the presence of an RBC flocculant, and in this manner form heavier particles that settle within the container/bottle/tube/collapsible bag or other vessel within which a sample/material is collected. Once the RBCs settle, the volume of the settled RBCs is recorded and employed together with a predetermined hematocrit of the mammal (animal/human), and a calculated RBC packing ratio associated with the collection vessel, so as to provide a real-time estimate of approximate blood volume in a liquid or mixed collected specimen.
In some embodiments, the flocculant is polydiallyldimethylammonium chloride (PolyDADMAC). Virtually any material or chemical may be used as a RBC flocculant in the practice of the present invention, as long as the material is able to facilitate the aggregation of RBCs to one another and decrease the time the RBCs aggregate and form a stable sedimentation level, preferably within about 15 minutes. The amount of RBC flocculant should be sufficient to facilitate the stable sedimentation of RBCs present in a fluid within less than about 60 minutes. In some embodiments, the amount of RBC flocculant should be an amount sufficient to facilitate a stable sedimentation of RBCs in a fluid within about 5 minutes, about 10 minutes, about 15 minutes, about 20 minutes, about 25 minutes or within about 30 minutes, or within a time range of about 5 minutes to about 20 minutes, at room temperature and in the absence of centrifugation. The amount of the RBC flocculant should be sufficient to impart a cationic charge to surfaces of RBCs in a liquid, such as a liquid comprising blood.
Molecules and materials for use as an RBC flocculant include polymeric RBC flocculants and non-polymeric RBC flocculants. For polymeric RBC flocculants, the RBC flocculant should have a molecular weight of at least about 100,000 Da, or about 200,000 Da, 300,000 Da or 400,000 Da, or a mixture of these, and have a relatively positive charge. By way of example, the polymeric RBC flocculants may include PEI, PAM, poly (acrylamide-co-acrylate), or any other relatively high molecular weight (greater than or equal to about 1,400,000 Da), positively charged polymer capable of imparting a positive charge to the surface of a RBC. Non-polymeric RBC flocculants may include acids, such as HCl or other acid molecule.
Other suitable high molecular weight cationic polymer RBC flocculants may be prepared by polymerization, such as by vinyl addition polymerization of one or more cationic monomers and by copolymerization of one or more cationic monomers with one or more cationic monomers. While cationic polymer RBC flocculants may be formed using cationic monomers, it is also possible to react certain non-ionic vinyl addition polymers to produce cationically charged polymers. Polymers of this type include those prepared through the reaction of polyacrylamide with dimethylamine and formaldehyde to produce a Mannich derivative.
The RBC flocculant may be used in solid form, in an aqueous solution, as a water-in-oil emulsion, or as dispersion in water. Representative cationic polymers that may be employed as an RBC flocculant include copolymers and terpolymers of (meth) acrylamide with dimethylaminoethyl methacrylate (DMAEM); dimethylaminoethyl acrylate (DMAEA); diethylaminoethyl acrylate (DEAEA); diethylaminoethyl methacrylate (DEAEM); or their quaternary ammonium forms made with dimethyl sulfate, methyl chloride, or benzyl chloride. In alternative embodiments, the RBC flocculant may comprise dimethylaminoethylacrylate methyl chloride quaternary salt-acrylamide copolymers, sodium acrylate-acrylamide copolymers and hydrolyzed polyacrylamide polymers.
After RBCs are settled within a collection device or in a collapsible bag designed to conform to the dimensions of a collection device including an RBC flocculant, or other suitable collapsible or non-rigid bag, a settled and/or sedimented RBC volume can be estimated by visual observation of graduated markings on the collection device and/or collapsible bag. that have been calibrated to provide a blood volume approximation. A red blood cell packing ratio 11 may be determined for a particular collection container and/or bag, to be calculated using a settled RBC volume, verses RBC sedimentation volume after centrifugation. With the determination of packing ratio, a total blood volume, such as a blood volume (Vb) or total amount of blood in a collected fluid, in the collection device can be estimated with the settled RBC volume (Vm), the subject's hematocrit (Hct) value (or an average HCT determined from a number of similar subjects), and the packing ratio η, according to the following formula:
V
b
=V
m/(Hct×η) 1)
Normally, in the absence of a flocculant, the RBC sedimentation rate, or erythrocyte sedimentation rate (ESR) is relatively slow, or not detectable to the unaided eye for several hours (See
Canisters, Collection Bags and Containers: Collection devices including canisters, collection bags and containers suitable for the collection and visual estimation of blood loss are provided. The collection devices may take the form of a round, square, octagonal, cylindrical, conical or virtually any configuration. The collection device should be sufficiently transparent or at least opaque so as to permit the visual detection of a level of material, such as sedimented RBCs, within the collection device. The collection device can be of a solid or flexible material, such as a hard plastic or glass, or a plastic material. The collection device may include a series of volumetric demarcations associated with the volume of the device itself, and an amount of an RBC flocculant suitable for facilitating RBC flocculation. The RBC flocculant may also be described as having a molecular weight sufficient to permit the settling of RBCs associated with the flocculant without centrifugation and at room temperature, within less than 30 minutes, or within about 5 minutes, about 10 minutes, about 15 minutes, or even about 20 minutes. The RBC flocculant may be provided in the collection device as a dry weight amount of flocculant, or as an amount of flocculant in a carrier solution, or as a pre-coating on the collection device (such as evenly coated on at least one surface, the entire surface, on a partial area, or as a strip along the inside of the device). These descriptions are provided by way of example and are not intended to provide limitation of potential embodiments envisioned for use and practice of the present devices and methods.
The following list presents an exemplary description of the treated and/or flocculant containing collection containers presented:
1,200 ml container (having a canister configuration), 5 ml and/or 10 ml graduated markings, one or more inlet ports, and one or more outlet ports (suitable for attachment of a tube suitable for imparting a suction so as to draw a fluid into the receptacle through a tube at the first inlet port).
500 ml container (having a canister configuration), 1 ml and/or 5 ml graduated markings, one or more inlet ports, and one or more outlet ports (suitable for attachment of a tube suitable for imparting a suction so as to draw a bio fluid into the receptacle through a tube at the first inlet port).
100 ml, 250 ml or 500 ml container (having a canister or conical configuration), 1 ml and/or 5 ml graduated markings), one or more inlet ports, one or more outlet ports, where at least one inlet port is suitable for attaching a tube for applying suction and drawing fluids and other materials into the container. These devices are particularly applicable for pediatric uses and smaller surgical procedures (sinus surgeries).
500 ml collapsible envelope (having 1 ml and/or 5 ml graduated markings, 1 or 2 inlet ports (resalable), and one or more outlet ports suitable for attachment of a tube suitable for imparting a suction to draw a fluid into the receptacle through a tube at the first inlet port).
100 ml, 200 ml, 250 ml, 300 ml, 400 ml, 500 ml, 1,200 ml, and 2,500 ml volume collapsible envelope (optionally having 5 ml and/or 10 ml graduated markings), 1 or 2 inlet ports (resealable) and one or more outlet ports (suitable for attachment of a tube for connecting the bag to a vacuum device, so as to draw a fluid into the receptacle through a tube at the first inlet port) (
The collapsible bag will also include a handle or other loop (
100 ml, 250 ml and 500 ml conical collection receptacle (optionally having 1 ml, 5 ml, and/or 10 ml graduated markings), an RBC flocculant, 1 or 2 inlet ports (resealable) and one or more outlet ports (suitable for attachment of a tube suitable for imparting a suction so as to draw a fluid into the receptacle through a tube at the first inlet port). These smaller collection devices have particular applications and provide greater accuracy for smaller (less than about 500 ml) blood volume monitoring. These smaller devices, and/or collapsible bags designed to fit within them that include calibrated blood volume markings specific for the conical receptacle size, are useful especially in neonatal, pediatric and other critical surgical situations.
Method of Estimating Blood Volume and Blood Loss in a Fluid: In another aspect a method of estimating blood volume in a liquid is provided. In particular embodiments, the method is used to estimate blood volume loss from a patient from fluid collected during a surgical procedure.
The method includes collecting a volume of liquid into a collection device that includes a RBC flocculant suitable for imparting a relatively positive charge to the surface of a RBC, for a period of time sufficient to permit RBC sedimentation by gravity within the collection device. The volume of sedimented RBCs after a sufficient period of time, together with an estimated hematocrit of the type of animal/human blood in the fluid, is used together with a calculated RBC packing ratio determined for the particular collection device, to calculate an approximate blood volume value in the liquid collected, using Equation 1 above. Alternatively, these calculations are provided in a calibrated marking panel called a Blood Indicator Panel (BIP), as part of the present invention, which may be included on a blood collection device. As such, an immediate and visual blood volume assessment may be provided as RBCs in fluid collected in the flocculant containing collection device sediments. In some embodiments, the BIP will include a calibrated marker coinciding to an estimated blood volume of 50 ml, 100 ml, 200 ml, 400 ml, and 600 ml, and a volumetric alignment marking for aligning the BIP within a conventionally volumetrically marked fluid collection device (every 5 ml, 10 ml, for example), such as is common on a conventional 1200 ml canister.
Blood Volume Assessment System: Fluid collection Canister and/or Envelope and Tubing System: The invention also provides a kit that will include any one or more of the above receptacles including an appropriate amount of an RBC flocculant and calibrated with blood volume demarcations, a first length of tubing suitable for aspirating a fluid from an area into a first port on the receptacle, a second length of tubing suitable for connecting with a source of suction and a second port of the receptacle, so as to impart a vacuum in the receptacle. The system may be provided as a kit, and may also include an instructional insert.
A Computer-Implemented Method for Estimating and/or detecting a Volume of Blood in a Fluid: Using a computer device, a user can more accurately and efficiently determine the volume of blood in a fluid, such as a surgical fluid from a subject. The method does not rely or use the transmission of a digital image of a surgical item or container. The method does not rely or require weight measurements of a surgical tools or materials, or multiple before and after use weight measurements of these materials.
The computer-implemented system provides for a user interface, where a user (i.e., medical professional, doctor, nurse, etc.) directly inputs data of at least a sedimented red blood cell volume in a container/collection device. The computer-implemented method provides for blood measurement as a function of sedimented and/or settled red blood cells in a fluid, and employing the volume level of sedimented and/or settled red blood cell in the fluid to determine a volume of blood in the fluid according to the algorithm:
V
b
=V
m
/Hct×η
Where Vb is the estimated blood volume, Vb is the level of sedimented and/or settled red blood cells in a fluid, Hct is a hematocrit value, and η is the packing ration of the red blood cells. For example, an average packing ratio of red blood cells in a sample of sedimented red blood cells. The hematocrit may be an average hematocrit for a particular animal or human (male or female), or may be the specific hematocrit for the specific patient from whom a fluid is being collected.
The user may directly input an observed sedimented and/or settled red blood cell volume to a central computerized system, and also transmit an image of the sedimented and/or settled red blood cell volume for an added quality control metric. This practice will provide a secondary quality check in the use of the system, and in the calculated volume of blood determined to be contained in a subject fluid according to the present methods.
The system will include a component, such as a hand-held unit, that provides for the display of a graphical user interface, including the graphical representation of the container and its display elements. For example, the graphical user interface may include a display prompting the user to input the volume of sedimented and/or settled red blood cells observed in a container and/or canister, at a single or a schedule of multiple defined time periods, such as at a defined standard time period schedule, including for example a 5 minute, 10 minute, 15 minute, 20 minute, and/or 30 minute, time reading of sedimented and/or settled red blood cell volume. The display elements may include user-manipulable sliding markers, or other suitable elements for receiving user input on specifics associated with the fluid being collected. For example, the addition and/or amount of saline or other fluid added into a container during a procedure, subject identifying information, subject specific and/or unique metrics, etc., notable sample fluid characteristics, etc., may be recorded.
In another aspect, the system and/or method is provided that is implemented employing a uniform resource locator (URL) located, for example, on a collection container or collection device. In this aspect, the user will image a URL element designed to associate with a specific webpage or other web resource. The webpage and/or web resource will include resource to apply the algorithm noted herein so as to provide an approximation of blood volume in a fluid. The computed blood volume will then be electronically transmitted to the user interface (device), and displayed on the user interface for the user (nurse, anesthesiologist, etc.) to easily and readily obtain an approximate blood volume. This system eliminates the requirement of the user to independently apply individual calculation steps, and thus reduces and/or eliminates potential user error.
These and other aspects of the invention are described below.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of skill in the art to which the disclosure pertains. Although any methods and materials similar to or equivalent to those described herein can be used in the practice or testing of the present technology, the preferred methods and materials are described herein.
As used here, the term “flocculant” is intended to mean a molecule that has a cationic charge that is capable of facilitating the coalescence of RBCs in a fluid at room temperature, and form a settled RBC mass with less than 30 minutes at room temperature without centrifugation. Reference to an element by the indefinite article “a” or “an” does not exclude the possibility that more than one element is present, unless the context clearly requires that there be one and only one element. The indefinite article “a” or “an” thus usually means “at least one.”
As used herein, “patient” or “subject” means an individual having symptoms of, or at risk for, cancer or other malignancy. A patient may be human or non-human and may include, for example, animal such a horse, dog, cow, pig or other animal. Likewise, a patient or subject may include a human patient including adults or juveniles (e.g., children). Moreover, a patient or subject may mean any living organism, preferably a mammal (e.g., human or non-human) from whom a blood volume is desired to be determined and/or monitored from the administration of compositions contemplated herein.
As used herein, “about” means within a statistically meaningful range of a value or values such as a stated concentration, length, molecular weight, pH, sequence identity, timeframe, temperature or volume. Such a value or range can be within an order of magnitude, typically within 20%, more typically within 10%, and even more typically within 5% of a given value or range. The allowable variation encompassed by “about” will depend upon the particular system under study, and can be readily appreciated by one of skill in the art.
The present example presents materials that may be used as RBC flocculants in fluid containing or suspected to contain blood. The following chemicals in Table 1 may be provided as RBC flocculants.
All the identified chemicals listed in Table 1 were tested and evaluated for suitability. Bovine whole blood purchased from Innovative Research (Novi, Mich.) was used to determine the suitability of each chemical above as a RBC flocculant. The whole blood contained with sodium citrate as the anticoagulant. The whole blood was diluted with saline to provide the following blood concentrations: 20%, 30%, 40%, 50%, 65%, and 80%, which were examined in the present studies.
Gelatin induced RBC aggregation but did not cause sedimentation. At the end, gelatin converted the entire blood/saline mixture samples into a gel structure. Without separating RBCs from the plasma and saline, gelatin is not suitable for this application.
Dextran 80+CaCl2) also converted the blood/saline mixture samples into gels instead of separating the RBCs from the blood plasma and saline.
Acid treatments of the blood/saline mixture samples were performed by adding 1.8% of high concentration acid 6N HCL. The pH of the samples was changed to about 4.5. The acid treatment caused aggregation and sedimentation of the RBCs. However, using relatively large amount of strong acid is not cost-effective for this application and it is difficult to handle strong acid in the process. Thus, acid treatment may be used to increase ESR.
PEI, a positively charged polymer, caused RBC sedimentation from the blood plasma and saline. The PEI must be dissolved under an acidic condition (i.e., with pH<7.0). In other words, a blood/saline mixture sample at neutral pH has to first have acid added to lower the pH before PEI can be used to facilitate RBC sedimentation in a biological fluid containing blood. The relative effectiveness of PEI and polyDADMAC were compared. The ESR (erythrocyte settling) induced by PEI was found to be lower than that of polyDADMAC. PEI is an acceptable flocculant for RBCs in a blood containing biological material (fluid).
PAM is a polymer that can be either negatively or positively charged. The negatively charged polymer will not induce the negatively charged RBCs to aggregate and settle. The positively charged PAM may be expected to be used for this application.
Alum is a positively charged molecule. It did facilitate a lower ESR, but at a much lower rate and amount. The relative molecular weight of a flocculant is considered for use as an appropriate flocculant because it enhances settlement of RBCs from gravity. In the studies with PEI and polyDADMAC, it was found that the higher molecular weight of those polymers caused faster RBC sedimentation.
PolyDADMAC is another positively charged polymer. It is also water soluble at neutral pH. PolyDADMAC in the presence of blood/saline mixture samples has the ability to rapidly cause RBC sedimentation. Only a small amount by weight of polyDADMAC is needed to induce the sedimentation. Quantitative studies are described below to determine the fraction of polyDADMAC needed proportionally to the amount of blood in a biological mixture containing blood. These studies also suggested that too great an amount of polyDADMAC may hinder, or even stop, RBC sedimentation. This may be because the RBCs become coated and surrounded by the positively charged polyDADMAC, and as such, the coated RBCs repel each other, by positive charges instead of negative charges, thereby hindering and/or preventing aggregation and sedimentation.
The low-cost, high molecular weight (at least 100 KDa, 200 KDa, 300 KDa or about 400 KDa), positively charged polyDADMAC was identified as a preferred, cost-effective flocculant to quickly induce RBC sedimentation. Other high molecular weight, positively charged polymer flocculants (e.g., PEI, PAM, etc.) would also be useful in the practice of the present methods and creation of container vessels. It is expected that an acid treatment would also be useful as part of the method to provide RBC sedimentation.
The present example demonstrates the material polyDADMAC as an effective flocculant for RBCs contained in a fluid, and the use of this flocculant for estimating total blood volume in a fluid that contains blood and other liquids, including saline.
High-molecular weight (at least 100, 200, 300 or 400 KDa) research-grade polyDADMAC was obtained from Sigma-Aldrich (Catalog number 409022 or 409030) along with industrial-grade polyDADMAC. The industrial-grade product is commercially available from Kemira Chemical under the product name “Superfloc C-591”, which contains a 20% concentration of polyDADMAC. This material is used in water treatment. Studies were performed to compare the effectiveness between the research-grade and industrial-grade products. The studies revealed that the Superfloc C-591 produced similar results in RBC sedimentation as the research-grade product. The cost of the industrial-grade product is lower than that of the research-grade product. The purity of C-591 varied, resulting in some differences in RBC flocculation. In the use of research grade and industrial grade polyDADMAC, the 20 wt. % in water stock solutions were diluted with water to 6.67 wt. % working solution to reduce the viscosity of the solution and to enhance ease of handling. The dry weight of flocculant for a 1200 ml collection canister was about 600 mg. of polyDADMAC.
Amount of Flocculant Needed to Facilitate RBC Sedimentation. Superfloc C-591 (obtained from the manufacturer (viscous liquid, 20 wt. % in H2O) was used as a RBC flocculant to test a bovine blood and saline mixture. The amount of flocculant needed to facilitate a more rapid RBC sedimentation rate was examined. It was discovered only about 0.4% (v/v %) of the Superfloc C-591 working solution added to the total blood/saline mixture volume was needed to provide an acceptably rapid (within 15 minutes) sedimentation of RBCs in the mixture. For example, in a 1-liter blood/saline mixture sample, only 4 ml of the Superfloc C-591 working solution was needed, regardless of the blood concentration in the mixture. This translates to about 320 mg of polyDADMAC flocculant for a 1.2 liter canister.
Tests also revealed lower or higher concentrations of the Superfloc C-591 working solution may be used. For example, concentrations as low as 0.3% (v/v %) and as high as 0.6% (v/v %) were found effective, however, the exact upper and lower limits were not determined. It was found that a 6% (v/v %) concentration of the Superfloc C-591 working solution added to blood/saline mixture sample with a 20% blood concentration induced minimal settlement, but that may not be the upper limit for sedimentation.
Aspect Ratio of Blood Container (Receptacle or Canister). During the experiments, it was found that the RBC sedimentation rate depends, in part, on the aspect ratio D:H of the container, where D is the diameter and H is the height of the container as shown, for example, in
Another finding during the experiments is that the Superfloc C-591 flocculant sedimented RBCs if it is placed in the container before adding the blood/saline mixture samples as well as when added to the container after it is already filled with the blood/saline mixture samples.
Sedimentation Rate and Blood Concentrations. The present studies indicated that the blood concentration in the blood/saline mixture also affects the RBC sedimentation rates, with a faster sedimentation rate in samples having a lower concentration of blood versus samples containing a higher concentration.
A graduated glass cylinder (
The settling RBC volume was set to 60 ml at time 0 since no visual separation had started at time 0. After time 0, the RBCs begin settling from the blood plasma/saline layer and initially settle toward the bottom of the container at a high sedimentation rate, but the sedimentation rate decreases over time. In this regard, as the amount of RBCs separated from the blood plasma/saline layer increases there are fewer RBCs to separate from the blood plasma and saline. Eventually, the RBC sedimentation rate is very low, so that the rate of RBC volume change is less than 5% per minute, or alternatively less than 5% per minute. At this point, the volume of settled RBCs is considered stable. In other words, a stable sedimentation is achieved when the volume change of the settled RBCs is less than 5% per minute, or alternatively, less than 5% per minute. The “packed RBC volume,” which is denoted as Vm, is the volume of the RBC layer at the bottom of the container when the RBC sedimentation is considered stable.
To ensure that the blood concentration in a fluid remains below about 50%, blood (for optimal RBC separation), additional saline or other appropriate blood diluent may be added. It was found that blood/saline mixtures with high concentrations of blood can still achieve a rapid sedimentation. One way in which sedimentation may be reinitiated should the sedimentation rate appear to be slowing down, one may add an additional volume of saline so as to further dilute the blood. Three 10 ml blood/saline mixture samples with 80% blood (bovine blood containing sodium citrate anti-coagulant) concentration were prepared in three bottles, as shown in
The 26.7% blood concentration mixture and the 40% blood concentration mixture achieved a stable sedimentation at around 10 minutes. The 53.3% blood concentration mixture achieved a stable sedimentation at about 16 minutes. As shown in
It should be noted that with other flocculants or other chemical treatments discussed above, further testing using the testing protocol previously outlined may be followed to determine optimal flocculant concentrations and blood/saline ratios.
Repeatability. The RBC sedimentation study using the 40% blood (bovine blood with sodium citrate anticoagulant) concentration mixture (
Total Blood Volume Estimation. To demonstrate the feasibility of estimating the total blood volume, an algorithm was developed to estimate the total blood volume in a blood/saline mixture based on the sedimented RBC volume Vm. If the actual RBC volume is denoted as Vc (as determined through centrifugation), the total blood volume is denoted as Vb, and the patient's hematocrit is denoted as Hct, then the following relationships are created:
η=Vm/Vc,Hct=Vc/Vb→Vb=Vm/(Hct×η)
Since Hct is available from the patient data measured prior to surgery and Vm is measurable based on the method described above, the total blood volume Vb can be estimated when the value of the packing ratio (η) between Vm and Vc is determined experimentally beforehand (methods and examples are presented herein, demonstrating the method for determining packing ratio η).
The values of the packing ratio η may be different for different blood types (e.g., human versus non-human). The packing ratio value is also likely to be container-specific in that it may vary according to the size and shape (aspect ratio) of the container used to collect the blood. In this regard, recall tests showed the container shape affected the ESR (Erythrocyte sedimentation rate). Thus, the packing ratio η should remain the same where the same blood type and container shape for blood measurement are used.
The packing ratio η is determined empirically by using a known hematocrit value and a known volume of blood within a blood/saline mixture. Preferably, the value of the packing ratio η will be determined by finding an average packing ratio value from numerous blood/saline mixture samples with different known blood concentrations. In this regard, by running a study with blood from the same species of animal (bovine, equine, human), and a container having a defined size and shape, in the presence of the flocculant as described herein, where different known blood/saline concentration mixtures are examined, an appropriate packing ratio η may be calculated. The greater the number of different blood/saline mixtures examined, the more statistically reliable the average packing ratio value derived will be. As discussed above, the blood concentration of a collected fluid in some embodiments should be about 50% or less blood. Additionally, an average hematocrit may be determined from a number of hematocrit values obtained from a representative number of subjects (animal/human). Hematocrit may be calculated using traditional capillary centrifugation methods, as known by those of skill in the art. The average hematocrit value for a group of animals, such as a group of humans or a group of horses, etc., will provide a value Vc that can be used in the formulas and methods described herein when the blood volume is known during the particular collection episode.
As noted, the value of the packing ratio η is preferably an average packing ratio value calculated from a group of blood/saline mixture samples in a defined collection container. The actual RBC volume Vc and the settled RBC volume (by ordinary gravity, at room temperature), Vm, facilitated in the presence of an RBC flocculant, will be determined for a number of individual samples, and an average packing ratio value determined. To determine the actual RBC volume Vc, the hematocrit of the blood added to a mixture sample is multiplied by the volume of blood added to that sample.
Next, the packed RBC volume Vm may be determined for each mixture sample using conventional volumetric graduated markings on a container, as described above. That is, with the flocculant present, the Vm may be determined by reading the volume of the RBC sedimentation. As part of the method, the same type and amount (concentration in the total fluid mixture volume) of RBC flocculant should be added to a collection container. As shown in table 2, even when the flocculant, polyDADMAC concentration was changed, the packing ratio η, remained relatively consistent. Thus, a range of flocculant concentrations (range of flocculant of about 0.3%, 0.4%, and 0.75% flocculant in the total liquid volume) can be used to induce RBC sedimentation without significantly affecting the packing ratio. In addition, the data in Table 2 demonstrates that the packing ratio is relatively insensitive to the amount of blood volume in the liquid mixture (blood/saline), when the flocculant concentration remains relatively the same.
With the actual RBC volume Vc and the settled, packed RBC volume Vm for each mixture sample, a packing ratio value, η value, for each sample (i.e., each different blood concentration mixture) can be determined. Then, an average packing ratio value may be calculated. For bovine blood, for example, the average packing ratio calculated was 1.61 (See Table 2).
To demonstrate the empirical determination of the packing ratio value, the value of the packing ratio η was determined for bovine blood purchased from a commercial vendor, these blood materials containing sodium citrate (for anticoagulant). Plastic canisters that were marked for volume (ml) were used, and are shown in
The packing ratio values that resulted from these experiments showed relatively small variations. In these experiments, the blood concentration of all blood/saline mixture samples in the chart above is less than 50% since mixtures with a higher amount of blood can be diluted to provide a mixture with less than 50% blood by adding saline. After determining that the Hct is 37.3%, and the mean packing ratio η value equals 1.61, the total blood volume in a blood/saline mixture can be estimated using the following formula (derived from Equation 1):
V
b
=V
m/(37.3%×1.61)=1.67×Vm.
The number 1.67 in the above formula is the calculated value of the 1/37.3% (average Hct)×1.61. (average η value from Table 2).
The following Table presents a comparison between the actual blood volume known to be present in each sample compared to the approximate volume (in ml) of blood in the sample determined through the calculation of blood volume determined using the formula above and techniques described here. The results demonstrate that the formula and techniques provided here may be used to provide an approximation of blood volume in a liquid sample containing mammalian blood (for example, bovine blood), in the presence of a RBC flocculant (for example, a polymeric flocculant such as polyDADMAC). In addition, the data shows that the approximated blood volume present in a collected mixed blood/saline liquid sample closely correlates with the actual blood volume in the liquid.
The 20% blood noted in Table 2 is composed of 200 ml bovine blood and 800 ml saline in every 1000 ml of fluid mixture.
The present example demonstrates the preparation of a particular fluid collection container with a RBC flocculant.
Blood Containing Liquid Collection Container. The fluid collection container used in the following examples was a 1200-ml suction canister, shown in
Flocculant—PolyDADMAC. Kemira's “Superfloc C-591” was used as the source of polyDADMAC. The quality or purity of this product was not consistent. Therefore, the Sigma-Aldrich version of high-molecular weight (200-350 KDa) 20% polyDADMAC (Sigma Catalog #409022) was used. The results indicate that the Sigma version of polyDADMAC significantly improve the testing results. However, it is anticipated that virtually any number of different sources flocculants may be used in the practice of the present invention, as well as in the fabrication of the herein described flocculant containing and treated fluid collection containers.
In the operating room, a biological fluid waste collection canister may be used to collect a volume of fluid, which will include an unknown volume of blood. The volume of blood in a canister volume of 1200 ml can vary anywhere from 10 ml to 1200 ml. The volume of blood in a collected fluid collected may also vary depending on specific species of animal, the gender and weight of the patient, as well as the particular medical procedure, being performed. However, the volume of blood in a collected fluid in a collection canister during a typical adult human surgical procedure is generally contains about 20% to about 50% blood. Conventional techniques for blood volume determination used in a standard hospital operating settings provide only gross estimations of blood volume that are most times inaccurate by at least 50%-75%, and are not available until hours after a surgical procedure has been completed.
In most cases, the amount of blood in an aspirated fluid during a surgical procedure is 50% or less. In those cases where the fluid contains more than 50% blood, the present methods and devices may be used to accurately determine blood volume by adding saline or other diluent to the fluid to lower the blood concentration, so as to facilitate the sedimentation of RBC's in the fluid in the presence of a RBC flocculant, polyDADMAC.
The present example demonstrates that a relatively constant amount of RBC flocculant, such as polyDADMAC, may be used to achieve a relatively accurate estimation of blood volume is a fluid containing about 50% or less blood concentration. This is achieved by using a visual reading of the volume of settled RBCs in a calibrated canister containing a RBC flocculant. This volume of settled RBCs is then used in a calculation to determine the volume of blood in the mixture. The settled RBC volume value alone is insufficient to accurately approximate blood volume in a mixture.
A test of 40% of blood at three different volumes of a blood/saline mixture was tested. The volumes of 40% blood/saline mixtures tested were: 200 ml, 800 ml, and 1200 ml. A Sigma-Aldrich polyDADMAC (20 wt. % in water) solution was diluted with saline to provide a working solution of 6.67 wt. % of polyDADMAC in water. This working solution was used to provide the appropriate amount of flocculant in this study.
Table 4 provides the optimal amount of flocculant for each volume of the 40% blood/saline mixture examined. The optimal amount of flocculant was identified as the amount of flocculant required to provide the fastest rate of red blood sedimentation out of the mixture. The RBCs in each of the mixture volumes examined achieved a visually discernable level of sedimentation in the canister, with a relatively clear fluid being observed above the visually discernable meniscus of settled RBCs at about 15 minutes after the blood/saline mixture had been combined with the flocculant at room temperature. It was observed that the rate of sedimentation varied depending on the amount of flocculant provided in the mixture.
From Table 4, an average of about 0.75 ml to about 1.5 ml of the flocculant working solution (about 50 mg to about 100 mg dry weight polyDADMAC) was optimal for promoting rapid RBC sedimentation in a 100 ml volume of the blood/saline mixture. For a larger 1,200 ml canister having a volume of about 1200 ml, about 9 ml of the polyDADMAC flocculant working solution (or about 600 mg dry weight polyDADMAC) would be provided in the bottom of the canister or on the canister walls to promote rapid RBC sedimentation is a volume of up to 1,200 ml of the blood/saline mixture. In the following studies, about 0.75 ml to about 1.5 ml of the flocculant working solution was used per 100 ml (or 0.75% v/v) of a blood/saline mixture. This concentration value is slightly larger than the 0.4% and 0.6% used in the studies described herein when using the industrial grade flocculant Superfloc C-591 version of polyDADMAC.
Based on the identified 0.75% v/v polyDADMAC concentration, a 1,200 ml canister that can collect up to 1,200 ml of a blood-containing fluid will need about 9 ml of the polyDADMAC working solution (or about 600 mg dry weight polyDADMAC).
Table 4 demonstrates the amount of flocculant that is optimal for achieving sedimentation of RBCs for different volumes of a 40% blood/saline mixture. As shown, 9 ml of the RBC flocculant polyDADMAC (about 600 mg dry weight) provided optimal RBC sedimentation in a volume of 1200 ml of the blood saline mixture.
The present example describes various methods in which a flocculant may be provided and distributed within and/or on a fluid collection container, particularly a fluid containing blood. While the specific polymeric flocculant, polyDADMAC, is used in the present example, many other polymeric and non-polymeric flocculant may be used in the practice of the present invention for providing the methods and devices described herein.
Vertical Band Coating on Canister Wall. A 1,200 canister was coated with a 9 ml volume of material that contained 600 mg flocculant. The canister was coated in the form of 1″ wide vertical band in the canister. This way, only flocculant immersed by the blood/saline mixture is dissolved or released into the mixture to cause RBC sedimentation. In other words, the vertical band of polyDADMAC coating can provide a control release of flocculant proportional to the volume of blood/saline mixture.
Two methods were used to apply the vertical band coating. One is to use a brush to provide a 1″ band directly on the canister wall. Another is to apply a flocculant coating on a 1″ wide clear tape, and then to adhere the clear tape to the canister wall. The canister has a hydrophobic surface such that it can be difficult for the flocculant solution to stay on the wall. An ozone treatment was developed to change the hydrophobic canister wall to hydrophilic. The flocculant adherence using this technique was improved.
After the coating of the vertical flocculant band, the canister was tested with bovine blood purchased from a commercial vendor. The canister with the flocculant band did facilitate RBC sedimentation. However, the sedimentation rate was somewhat slower. It took more than 20 minutes for the RBC to settle at bottom of the canister. Generally, a faster rate of RBC sedimentation is desired. While not intending to be limited to any theory or specific mechanism of action, the slower rate may be related at least in part to the time needed for the flocculant coating to dissolve and spread throughout the entire blood/saline volume. It takes more time to spread the flocculant from single-band coating to the entire blood/saline mixture. A thinner coating that is distributed throughout the entire canister is expected to accelerate the dissolution and distribution of the flocculant.
Uniform Coating on Entire Canister using the Ultrasound Atomization Technology. An ultrasound based method was used to coat the interior of a blood collection canister. Ultrasound atomization coating is a pressureless, low-velocity (typically on the order of 3-5 inches per second) coating that differentiates itself from spray coating. Piezoelectric transducers convert electrical input into mechanical energy in the form of vibrations. The high frequency sound vibration atomizes liquid into a fine mist spray (
Multiple parameters were tested, using different concentrations of polyDADMAC, and incorporating high vaporized alcohol, like methanol and ethanol, into the spray solution to accelerate the drying process. The polyDADMAC working solution (prepared in DI (de-ionized) water) provided an optimal misty spray to deposit the flocculant using an ultrasound atomization device at the intensity setting of “10” (
Between each coating, the canister was allowed to dry completely, either inside an oven for couple of hours or under room temperature for 24 hours.
The flowing protocol provides the manual steps for preparing the flocculant treated (coated) canisters:
Preparation for the Coating
1. Prepare polyDADMAC working solution by mixing one part of 20 wt. % polyDADMAC (Sigma Catalog #409022) with two parts of DI water.
2. Fill a 60 ml syringe with the polyDADMAC working solution.
3. Set the ultrasound atomization device at the intensity setting of “10”.
4. Set the syringe pump rate at 60 ml/hr., and volume deliver of 4.5 ml.
Manual Coating Process
1. Turn on the ultrasound atomization device, start moving the ultrasound nozzle from the bottom of the canister applying misty spray on the wall and bottom of the canister.
2. Gradually moving the ultrasound nozzle from bottom to the top of the canister following the spiral path and ensuring everywhere on the wall is coated with polyDADMAC. 3. 3. The regions coated with the polyDADMAC mist show misty looking as seen in the picture shown herein in the Figures.
3. Typically, the 4.5 ml diluted polyDADMAC is sufficient to provide one coating to the entire canister.
4. Let the coated canister to dry overnight at the room temperature.
5. After the dry of the first layer of coating, a second layer is applied to the canister in the same way as described above. A total of 9 ml of diluted polyDADMAC will be applied on the canister after two layers of coating.
6. Dry the canister again overnight, then the canister is ready to be used.
The polyDADMAC coated 1200 ml canister was prepared using a canister having a volume of 1,200 ml, and having the dimensions of a biological waste canister employed in operating rooms. A typical organization of such a canister in an operating room setting is provided in
Bovine blood purchased from a commercial vendor was used in the present study. This blood had been refrigerated, and then warmed to 23° C. at the time of testing. In addition, the bovine blood contained sodium citrate in order to prevent coagulation.
Bovine blood and saline were added to a flocculant treated canister so as to achieve a defined ratio of blood/saline. To simulate the process in which a liquid containing blood would be provided into a collection canister during a routine operation, for example, a 600 ml volume of a blood/saline mixture (40% blood) was delivered to a flocculant treated canister according to the following technique. A container A was prepared to include 240 ml of blood, and a container B was prepared to contain 360 ml of saline. A serological pipet was used as the aspiration probe. The aspiration probe was connected to an inlet port (the patient port) on the canister via tubing. The canister was further connected to a vacuum line using a second port on the canister, and used to impart a vacuum in the canister. Under vacuum, the pipet was placed in the container including blood or the container including saline to aspirate the respective fluid alternatively into the flocculant containing canister (polyDADMAC) (
After all of the blood and saline had been aspirated into the third canister, the mixture was monitored to assess separation/settlement of the RBCs apart from the plasma and saline, in the presence of the flocculant. The volume of the RBC settlement line was recorded every minute for 20 minutes.
The study was conducted using different volumes of the 40% blood/saline mixture solutions (200 ml, 400 ml, 800 ml and 1200 ml). Each study was repeated three times.
With a 20% blood mixture (20% blood/80% saline), the RBCs settled very quickly in the flocculant treated canister. A visually observable settlement of RBCs of 30 ml (Vm) was reached within 10 to 15 minutes at room temperature (
These experiments demonstrate the polyDADMAC coating facilitated the rapid sedimentation of RBCs out of the blood/saline mixture at room temperature within 15 minutes. The sedimentation of RBCs in these blood/saline mixtures at room temperature in the absence of a flocculant would have required 3-6 hours.
Estimation of the Packing Ratio Using the data from the above experiments, the packing ratio η (see Equation 1) between the settled RBC volume (Vm) and the actual RBC volume (Vc) can be determined empirically. Table 5 illustrates the empirically determined packing ratio for the 1200 ml Medi-Vac canister, which has the average value of 1.20. Since the packing ratio covers a large range of volumes from 200 to 1200 ml as well as a large range of blood concentrations, the variance of the packing ratio is relatively high, above 13%. These variations in packing ratio also affect the variance in blood volume loss estimation. The following packing ratio η values were calculated for each of the respective blood mixtures. An average value η was then calculated.
In this study, the average hematocrit value of bovine blood used was 35.4%, and the derived average packing ratio 11 was 1.2. Using the formula at Equation 1, the following formula was created to estimate the volume of blood in a fluid collected in the flocculant containing canister:
V
b
=V
m/35.4%×1.2=2.35×Vm
The estimate of blood loss for each of the blood mixtures 1-8 are presented in the following Table 6, and compared to the known amount of blood in the sample.
As demonstrated in the table above, the amount of blood loss calculated using the present formula was correlated with the actual amount of blood in the fluid. The present methods and devices therefore are demonstrated to provide a contemporaneous visual indicator tool of blood volume loss for the physician/health care professional in a surgical setting, which is more accurate than conventional approaches (saline bag use assessment and/or post-surgery estimation from total patient fluid collection).
Based on an observed volume (in ml) of settled RBCs in a graduated canister in the presence of a flocculant, without the requirement of any electrical, temperature, or other material manipulating procedure, a Blood Indicator Panel was devised using the above formula, that provides an immediate visual tool for total blood volume approximation in a collected fluid.
For a user to easily estimate blood volume via a visual inspection of settled RBCs in a receptacle (such as a flocculant containing canister), a blood volume indicator panel with calibrated markings is provided for a fluid collection receptacle, and will indicate a total blood volume approximation in a collected fluid, from the level of settled RBCs in the presence of a flocculant in the collection receptacle. It is envisioned that these collection receptacles may or may not include conventional volumetric measures.
To create the graduated marking for the blood volume indicator panel of the present receptacles (canisters, etc.), the following Equation 2 is used:
V
m
=V
b
×Hct×η
The Equation 2 will employ an average Hct calculated from a number of animals/human from the same species, and of the same approximate age and gender. For example, for an adult human male, the average Hct is about 45%.
In this study, a blood indicator panel for a large mammal was created using the formula:
V
n=0.43×Vb Equation 3:
The formula will use and average Hct in bovine blood of 35.4%, and an average packing ratio η=1.20, as calculated for bovine blood (Table 5).
A 50 ml estimated blood volume mark is provided on the blood volume indicator panel, which corresponds to a visually discernable settled RBC volume of about 21.5 ml. using the Equation 3 (See Table 7). A 100 ml estimated blood volume calibrated mark can be generated on the blood volume indicator panel that corresponds to about the 43.02 ml of the settled RBC volume line of the receptacle, and so forth.
The graduated markings of the blood volume indicator panel provide a series of visually identifiable markings that do not relate to a measure of the volume of material in the canister, but instead to an approximation of the blood volume in the fluid collected in the canister. An illustration of a typical blood indicator panel (BIP), is provided in
The BIP Panel is created based on the derivation of an average hematocrit (Hct), for example, the average Hct for human, bovine, equine, etc. To correct for Hct differences in individual patients/animals, such as differences in individual Hct due to gender, species, age, etc., the approximate blood volume value indicated on the BIP may be adjusted by a factor that corrects for significantly higher or lower individual hematocrit values. For example, if the measured Hct value from a patient is lower, for example, 80% of the typical Hct of an adult human male, then the blood volume indicator value on the panel observed for that patient will be divided by 80%, so as to provide an even closer approximation of the estimated blood volume in the receptacle. More particularly, if the blood volume indicator value on the panel is 50 ml according to the graduated markings on the indicator panel, the actual blood volume in the biological material collected from this patient would be calculated to be 62.5 ml where the patient's Hct is 80% of the typical Hct value. Similarly, if the measured Hct value of a patient is higher, for example 110% of a typical adult male hematocrit value, then the blood volume indicator value on the blood volume indicator panel would be divided by 110%, which will yield a lower blood volume. For example, if the blood volume indicator value on the blood volume indicator panel is 100 ml, then the actual blood volume loss for the patient would be calculated to be 90.9 ml, so as to correct for the patient's higher than average Hct. (e.g., 10% higher).
The particular Blood Indicator Panel as placed on a collection canister is shown in
This study successfully developed the prototype for a BIP using a RBC flocculant, polyDADMAC coated biological fluid collection canister (1200-ml). This size canister is used in operating rooms for human patients, adult and pediatric. The evaluation of the prototype using bovine blood has shown a quick sedimentation of RBCs in the presence of this exemplary RBC flocculant, and the achievement of stable RBC sedimentations within 20 minutes. Calibrated markings on the specially designed BIP were designed for this collection canister, and may be used to provide a visual estimation of total blood volume in a collected mammalian liquid. If the patient's measured hematocrit is different from the typical hematocrit used to create the calibrated BIP markings, the calibrated blood volume can be corrected to accommodate the percent blood hematocrit to the individual blood volume amount.
The following provides the average hematocrit for an adult man and for an adult woman:
A 100 ml canister was prepared, to contain about 50 mg flocculant. In this example, the RBC flocculant used was polyDADMAC. The flocculant was provided in a volume of the polyDADMAC working solution described herein.
In a typical operating room setting, smaller volumes of fluid containing blood and other materials (tissue, urine, non-blood fluid, etc.) will be aspirated from a surgical field. The aspiration of these fluids results in an undetermined loss of blood from the patient. A smaller container may be prepared according to the present invention to accommodate the estimation of blood loss in these small, sometimes critical, volumes of collected fluid. Therefore, these 100 ml receptacles containing a RBC flocculant, such as polyDADMAC, are provided and are especially useful for determining blood volume in small amounts of collected fluid. These devices may be used, for example, in pediatric applications (infant) as well as in low volume critical fluid collection procedures.
The aspect ratio of the 100 ml collection device was calculated to be 0.96. The small 100 ml container with the RBC flocculant was used in the study described in Example 9.
The present example is provided to demonstrate the utility of the methods and devices for use for estimating blood loss in a fluid containing mammalian fresh blood (no anti-coagulants). In this example, a non-blood material present in the fluid was saline. The present example examines a technique for estimating blood loss using fresh, never refrigerated, volume of mammalian blood. Further, the blood did not contain calcium citrate, or any other anti-coagulants. In the present study, the fresh blood specimen was obtained from an adult horse. Thus, the devices and methods are especially useful in the approximation of blood loss in mammals, including humans and veterinary animals (horses, dogs, cats, cows, bulls, sheep, pigs, etc.).
In this example, blood was collected from a live, adult horse (approximately 12 years old, weight 1,200 pounds), having no known clinical pathologies, and not on any known medications. The animal was being treated for a lame foot, and was being given a nerve block to manage pain. Unlike blood collected from a commercial vendor, which contains an anticoagulant such as sodium citrate (used in the prior examples), no anticoagulants or other drugs were present in the blood collected from the horse used in this study.
A total of twelve (12) canisters having a total volume capacity of 100 ml were used in the present study. The canisters were marked with demarcations along the side of the canisters at 50 ml and 100 ml increments. The aspect/ratio of the 100 ml container, D:H (Diameter vs. Height) was calculated to be about 0.96. Comparatively, the aspect ratio of the 1200 ml canister is about 0.61. Typically, the larger the aspect ratio of the collection device, the more quickly RBCs contained within any blood in the collected liquid will settle out in the collection device. Therefore, the rate of RBC sedimentation in the 100 ml collection device was expected to be more rapid compared to the sedimentation rate of RBCs in a 1200 ml canister, in the presence of the RBC flocculant, under similar conditions.
The 100 ml dry canisters received 50 mg of the RBC flocculant, polyDADMAC, research grade (Sigma Catalog #409022). (See Example 7). Other RBC flocculants, as well as industrial grade versions of these flocculants, including PEI, PAM and others, may be expected to be useful in the present methods and devices.
The amounts of fresh equine blood and saline indicated in Table 8 were then added to each of the canisters, and RBC sedimentation volume was recorded every minute for 20 minutes:
Blood from an adult horse was drawn, and a volume of the fresh blood at body temperature was added to each of the canisters in the amounts indicated above. The top on each of the canisters was then put in place, the contents mixed so as to assure proper mixture of saline, blood and flocculant. Each canister was allowed to sit undisturbed at room temperature, and observed. The time at which sedimentation of RBCs was observed was recorded at 1 minute intervals up to 30 minutes.
Table 9 presents the hematocrit of various large animals. The values for mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), and packed cell volume (PCV), and may be employed in providing an appropriate customized Blood Indicator Panel and blood volume approximation method as described in the present disclosure.
The present example was performed with fresh blood drawn from an adult horse (12 years old, about 1,200 pounds). The horse blood did not contain any anticoagulant. The hematocrit of horse blood is between 32% and 53%. The horse blood was used immediately after having been drawn, and was at body temperature (about 101° F., 38.3° C.) at the time it was combined with saline in the presence of flocculant, polyDADMAC (600 mg).
A 1,200 ml canister that had been coated by spray application of about 9 mls of polyDADMAC working solution as the flocculant was used. Thus, the 1,200 ml canister was coated evenly with a total of about 600 mg dry weight polyDADMAC as the flocculant. Because the flocculant was evenly distributed along the walls of the canister, the amount of flocculant is released in proportion to the volume of fluid provided in the treated canister.
The following volumes of settled RBCs were recorded over time.
A volume of 400 ml fresh horse blood (not refrigerated, body temperature, no anti-coagulants), was placed in the treated canister. A known volume of 250 ml saline was added to the canister. The total volume was 650 ml of fluid in the canister. This provided a 61.5% blood solution. The volume of settled RBCs (gravity only, no centrifugation), Vm, was recorded immediately upon mixing, up to a period of 30 minutes.
After being allowed to settle undisturbed for 30 minutes, the canister was manually agitated, and then allowed to sit at room temperature again. The agitated blood containing canister was again observed for evidence of settlement of RBCs at room temperature.
At the end of the 30 minute observation period, the canister was manually shaken, and allowed to sit. The re-sedimentation of RBCs occurred, and was observed every minute for 30 minutes, and resulted in the observation of settled RBC levels as indicated in Table 14.
From this study it is demonstrated that the settled volume of RBC's in a solution containing whole fresh blood remains relatively stable up to about 30-40 minutes at room temperature. With agitation, it appears that RBCs in the fresh blood sample again settled to provide a discernable RBC sedimentation volumetric line, Vm, very quickly (3 to 4 minutes verses 16-19 minutes, settled RBC volume about 250 ml to 300 ml.). The actual known volume of fresh blood present in the fluid was 400 ml.
The total approximation of blood volume may be calculated by the formula using the average hematocrit of the type of animal (42.5%, horse average Hct), the Vm (observable settled RBC volume in ml), and a new packed ratio value (n) determined for horse blood via experimentation with multiple equine blood sample assessments of settled RBC volume (Vm) and Hct information, a visual Blood Indicator Panel may be created and provided along the vertical axis of a collection canister for use with large animals, such as horses. This would provide an immediately visually discernable approximation of blood volume in a biological fluid containing horse blood. The development of a Blood Indicator Panel for a treated canister or other receptacle may be used to provide a visual indicator of equine blood volume loss, and especially for assessing a more exact equine blood loss, than is presently available. An equine Blood Indicator Panel may be developed employing the information and results presented here, by one of ordinary skill in the veterinary arts, without more than ordinary and routine experimental optimization trial and error.
The present example is provided to provide canisters and methods for efficient measurement of blood loss in a pediatric patient. As used in the present example, a pediatric patient is defined as an individual up to 12 years of age having a body weight of up to 70 to 80 pounds.
A person's total blood volume (TBV) is related to body weight. The TBV of a child is around 75-80 ml/kg and is higher in the neonatal period (from 85 ml/kg it rises to a peak of 105 ml/kg by the end of the first month and then drops progressively over ensuing months). Thus, the TBV of a 3.5-kg 2-week-old will be about 350 ml while that of a 10-kg 15-month-old will be about 800 ml.
Because of the much reduced total volume of blood in a pediatric patient, it is especially important to provide a blood collection and blood loss estimation system and device that are designed for estimating blood loss accurately from a smaller volume of blood collected from a pediatric patient. The specifically designed pediatric blood loss estimation devices of the present invention are therefore crafted with a container having the herein described flocculant and canister demarcations with a total volume capacity of less than 1000 ml, such as about 500 ml or even about 250 ml, in the case of an infant or neonate.
A large acute loss of blood volume in a pediatric patient may compromise the circulation, and therefore blood loss should be carefully monitored so as to be able to detect a volume of blood loss of about 12% of the TBV (around 10 ml/kg) of the specific pediatric patient, assuming the child is in a stable condition and has a normal blood hemoglobin (Hb) level at the beginning of a procedure.
By way of example, a suitable pediatric blood loss collection device would, in some embodiments, have a capacity of 250 mls. The canister would preferably provide an appropriate aspect ratio of D:H for a typical pediatric blood loss volume. The D (diameter) of the device would typically be between 2 and 3 inches, and have an H (height) of about 2 inches to about 3 inches. With these smaller dimensions, a collected blood loss volume would provide a reasonably rapid yet monitorable sedimentation rate of RBCS so as to alert an attending physician if an amount of blood loss has reached a volume where transfusion to the pediatric patient is in order. It would be preferred that a sedimentation rate would be achieved that provides for RBC sedimentation within 15 minutes of blood collected in the canister.
In some embodiments, the 250 ml container has a conical shape (
The amount of flocculant to be added to a 250 ml collection device would be about 50 mg to about 150 mg, or about 125 mg, or an amount sufficient to achieve at least a 0.3%, 0.4% or 0.75% of total volume of the solution.
For sake of description, the following average total blood volume in a pediatric group of patients may be used in calculating when a 12% or greater blood loss has occurred. An average hematocrit value may also be calculated for the class/group (premature neonate, full term neonate, infant) of pediatric patients, and a marking provided alongside one axis of the canister, of average hematocrit values for these patient groups, so as to provide a ready visual reference for the attending physician or anesthesiologist to refer to and compare as against the hematocrit obtained for the patient undergoing the procedure:
The total approximation of blood volume may be calculated by the formula using the average hematocrit of for a human child of a particular weight range and/or age, or for a human adult male or adult female, the Vm (observable settled RBC volume in ml), and the packed ratio value (n) determined for human blood. With multiple human blood sample assessments of settled RBC volume (Vm) and Hct information, a visual blood volume indicator panel to be located along the vertical axis of the collection canister may be prepared for the human, and especially for a pediatric human model. This would provide an immediately visually discernable approximation of blood volume in volumes less than about 250 ml, contained in a biological fluid containing human blood. The development of a vertical canister or other receptacle having a Blood Indicator Panel for human blood volume assessment in a liquid, and especially for assessing small volumes of human blood loss, may be developed by one of ordinary skill in the art given the teachings provided herein, without more than a routine and ordinary amount of trial and error.
The present example presents a collapsible plastic-like container (bag) that may be used to collect biological fluid loss, and used to estimate blood loss. Such a collection device is envisioned to be especially useful in combat situations, or any other situation where space for medical equipment is limited.
It is envisioned that the plastic bag containers will include an amount of an RBC flocculant suitable for providing the RBC sedimentation and the blood loss estimate features described herein. In some aspects, the bag could be placed within a supporting container, such as a box, canister, or other structure. The bag may also include a number of markings along the vertical axis of the bag, corresponding to volumetric measures (such as milliliters).
In some aspects, a clear plastic bag having a volume capacity of about 1,000 ml containing between about 300 milligrams and about 4,700 milligrams of a flocculant, such as polyDADMAC, will be placed in the bag. The bag will include, in some embodiments, calibrated demarcations at a 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 600 ml, 750 ml and 1 liter marker. The bag may also include a BIP, such as in the form of an adhesive strip, which may be placed on the bag and used to provide a visually discernable indicator of approximated blood volume in a liquid based on the settled RBC level in the collection bag/container. An exemplary rendition of this embodiment is provided at
The flocculant containing canisters (1.2 ml, 500 ml., 250 ml., 10 ml), that includes a blood volume indicator panel, may be provided together as a kit with a length of aspiration tubing and a second length of tubing suitable for adding saline into a canister and/or collapsible envelope.
An instructional insert may be provided as part of the kit for the end user.
This example demonstrates the stability of the RBC flocculant polyDADMAC and retained activity for providing RBC coalescence (flocculation) in a fluid containing blood, after exposure of the polyDADMAC coated canister to high temperatures.
In the present study, the flocculant used was polyDADMAC provided as a coating on a canister for collecting a material, such as a biological liquid material collected during a surgical procedure that will contain a component of blood. The coated canisters were incubated at 55° C. for 6 weeks (equivalent to one-year shelf life at room temperature). The coated canisters, after high temperature aging, were then compared in the function test with the coated canister without going through the high temperature aging test.
Materials:
Methods:
Results:
The data illustrates a closely overlay of the volume change curves of RBC settlement in the 20% blood test. All RBC volume settlement levels were stabilized around 125 ml at about 15 minutes after the mixtures were introduced into the control (
In the 40% blood test, although the volume settlement of one experiment lagged, the volume of settled RBCs was stabilized at about the 125 ml volumetric mark after 15 minutes.
The studies demonstrated no discernable difference in the function between the control and experimental canisters after heat treatment. The polyDADMAC coated canisters, after six-week of aging test under 55° C., show no functional degradation of the polyDADMAC or decrease in effectiveness for facilitating floculation of RBCs in a liquid. The floculent coated canisters (polyDADMAC coated canisters) are expected to have at least a one-year shelf life without loss of the flocculant activity to provide blood volume estimation in a fluid stored at room temperature.
The present example is presented to demonstrate the method of estimating human blood volume in a fluid in the presence of a flocculant. The present example also demonstrates the detection of human blood in a fluid sample.
Adult Male, 61 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline and patient fluid material from sinus surgery.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 72 years, Collection of Fluid attendant a Lobectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 700 ml saline and 200 ml patient fluid material from surgery.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 46 years, Collection of Fluid attendant a Hysterectomy
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline and 75 ml patient fluid material from surgery. Total volume 700 ml.
650 ml Saline added.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 41 years, Collection of Fluid attendant a Hysterectomy
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline added and 55 ml patient fluid material from surgery.
450 ml of saline added. Total volume 500 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 41 years, Collection of Fluid attendant a Heart Bypass
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 600 ml saline and 300 ml patient fluid material from surgery. 600 ml of saline added. 900 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 61 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery. 500 ml of saline added. 900 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 61 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 600 ml saline to 85 ml patient fluid material from surgery. 500 ml of saline added. 600 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 75 years, Collection of Fluid attendant a Lobectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 750 ml saline to 300 ml patient fluid material from surgery. 750 ml of saline added. 1100 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 75 years, Collection of Fluid attendant a Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 55 ml patient fluid material from surgery. 50 ml of saline added. 100 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 65 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 400 ml saline to 200 ml patient fluid material from surgery. 400 ml of saline added. 600 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 65 years, Collection of Fluid attendant a Partial Mastectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 400 ml saline to 300 ml patient fluid material from surgery. 400 ml of saline added. 600 ml total volume.
Time for red blood cell sedimentation/settled RBC volume:
Adult Male, 45 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery. 500 ml of saline added.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 20 years, Collection of Fluid attendant a Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 60 ml saline to 55 ml patient fluid material from surgery. 60 ml of saline added.
Total volume 180 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 46 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 75 ml patient fluid material from surgery. 650 ml of saline added.
Total volume 700 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 46 years, Collection of Fluid attendant a Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. 50 ml of saline added.
Total volume 120 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 55 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 75 ml patient fluid material from surgery. 50 ml of saline added.
Total volume 700 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult Male, 62 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. 50 ml of saline added.
Total volume 110 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult Male, 68 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery. 500 ml of saline added.
Time for red blood cell sedimentation/settled RBC volume:
Adult Male, 62 years, Collection of Fluid attendant a Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. 500 ml of saline added.
Total volume=120 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult Female, 72 years, Collection of Fluid attendant a Heart Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 400 ml patient fluid material from surgery. 650 ml of saline added.
Total volume=1000 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 61 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery. 500 ml of saline added.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 72 years, Collection of Fluid attendant Lobectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 700 ml saline to 200 ml patient fluid material from surgery. Total volume 900 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 72 years, Collection of Fluid attendant Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 75 ml patient fluid material from surgery. Total volume 500 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 41 years, Collection of Fluid attendant Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 450 ml saline to 55 ml patient fluid material from surgery. Total volume 500 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 69 years, Collection of Fluid attendant Heart Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 600 ml saline to 300 ml patient fluid material from surgery. Total volume 900 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 61 years, Collection of Fluid attendant Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to 300 ml patient fluid material from surgery. Total volume 900 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 39 years, Collection of Fluid attendant Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 600 ml saline to 85 ml patient fluid material from surgery. Total volume 600 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 75 years, Collection of Fluid attendant Lobectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 750 ml saline to 300 ml patient fluid material from surgery. Total volume 1100 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 62 years, Collection of Fluid attendant Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 55 ml patient fluid material from surgery. Total volume 100 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 65 years, Collection of Fluid attendant Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 400 ml saline to 200 ml patient fluid material from surgery. Total volume 600 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 75 years, Collection of Fluid attendant Partial Mastectomy
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 400 ml saline to 300 ml patient fluid material from surgery. Total volume 600 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 46 years, Collection of Fluid attendant Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 75 ml patient fluid material from surgery. Total volume 700 ml.
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 45 years, Collection of Fluid attendant Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery.
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 62 years, Collection of Fluid attendant Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to patient fluid material from surgery.
Time for red blood cell sedimentation/settled RBC volume: 65 ml patient fluid from surgery. Total volume 110 ml
Adult male, 62 years, Collection of Fluid attendant Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. Total volume 120 ml
Time for red blood cell sedimentation/settled RBC volume
Adult male, 18 years, Collection of Fluid attendant Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. Total volume 120 ml
Time for red blood cell sedimentation/settled RBC volume
Adult male, 18 years, Collection of Fluid attendant Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. Total volume 120 ml
Time for red blood cell sedimentation/settled RBC volume
Adult male, 18 years, Collection of Fluid attendant Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 50 ml saline to 65 ml patient fluid material from surgery. Total volume 120 ml
Time for red blood cell sedimentation/settled RBC volume
Adult female, 68 years, Collection of Fluid attendant Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery.
Time for red blood cell sedimentation/settled RBC volume
Adult female, 72 years, Collection of Fluid attendant Heart Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 400 ml patient fluid material from surgery. Total volume 1000 ml.
Time for red blood cell sedimentation/settled RBC volume
Adult female, 18 years, Collection of Fluid attendant Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 300 ml saline to 55 ml patient fluid material from surgery. Total volume 355 ml.
Time for red blood cell sedimentation/settled RBC volume
Adult female, 18 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 600 ml saline to 150 ml patient fluid material from surgery. Total volume 750 ml.
Time for red blood cell sedimentation/settled RBC volume
Adult female, 43 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to 125 ml patient fluid material from surgery. Total volume 625 ml.
Time for red blood cell sedimentation/settled RBC volume
Adult female, 57 years, Collection of Fluid attendant a Partial Mastectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 200 ml saline to 25 ml patient fluid material from surgery. Total volume 225 ml.
Time for red blood cell sedimentation/settled RBC volume
Adult female, 68 years, Collection of Fluid attendant a Mastectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 550 ml saline to 200 ml patient fluid material from surgery. Total volume 750 ml.
Time for red blood cell sedimentation/settled RBC volume
Adult Male, 73 years, Collection of Fluid attendant a Prostate Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 520 ml saline to 300 ml patient fluid material from surgery. Total volume=820 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 69 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to 300 ml patient fluid material from surgery. Total volume=800 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 66 years, Collection of Fluid attendant a Hip Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 520 ml saline to 655 ml patient fluid material from surgery. Total volume=1175 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 41 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to 275 ml patient fluid material from surgery. Total volume=775 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 46 years, Collection of Fluid attendant a Mastectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 325 ml saline to 200 ml patient fluid material from surgery. Total volume=525 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 15 years, Collection of Fluid attendant a Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 535 ml saline to 120 ml patient fluid material from surgery. Total volume=655 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 62 years, Collection of Fluid attendant a Sinus Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 600 ml saline to 200 ml patient fluid material from surgery. Total volume=800 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 58 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 400 ml saline to 200 ml patient fluid material from surgery. Total volume=600 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 67 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 300 ml saline to 200 ml patient fluid material from surgery. Total volume=500 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 76 years, Collection of Fluid attendant a Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 60 ml saline to 90 ml patient fluid material from surgery. Total volume=150 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 41 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to 90 ml patient fluid material from surgery. Total volume=735 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 65 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to patient fluid material from surgery. Total volume=600 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 65 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to patient fluid material from surgery. Total volume=600 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 75 years, Collection of Fluid attendant a Heart Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 850 ml saline to patient fluid material from surgery. Total volume=1200 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 57 years, Collection of Fluid attendant a Mastectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 200 ml saline to patient fluid material from surgery. Total volume=600 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 45 years, Collection of Fluid attendant a Neck Mass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 75 ml saline to patient fluid material from surgery. Total volume=155 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult male, 45 years, Collection of Fluid attendant a Tonsillectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 300 ml saline to patient fluid material from surgery.
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 65 years, Collection of Fluid attendant a Lobectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 650 ml saline to patient fluid material from surgery. Total volume 1000 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 71 years, Collection of Fluid attendant a Hip Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 450 ml saline to patient fluid material from surgery. Total volume 800 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 64 years, Collection of Fluid attendant a Lobectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 450 ml saline to patient fluid material from surgery. Total volume 800 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 53 years, Collection of Fluid attendant a Nasal Surgery.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 500 ml saline to patient fluid material from surgery. Total volume 500 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 53 years, Collection of Fluid attendant a Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 150 ml saline to patient fluid material from surgery. Total volume 450 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 72 years, Collection of Fluid attendant a Femoral Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 250 ml saline to patient fluid material from surgery. Total volume 400 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 78 years, Collection of Fluid attendant a Heart Bypass.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 675 ml saline to patient fluid material from surgery. Total volume 1100 ml
Time for red blood cell sedimentation/settled RBC volume:
Adult female, 48 years, Collection of Fluid attendant a Hysterectomy.
The flocculant used was poly diallyldimethyl ammonium chloride.
Mixture of 55 ml saline to patient fluid material from surgery. Total volume 400 ml
Time for red blood cell sedimentation/settled RBC volume:
The present example provides an alternative configuration of the canister having a slightly tapered configuration. A diagram showing the canister of the present invention having a slightly tapered configuration is provided at
As shown, the interior of the canister wall 5 is prepared to include particles 1 of a red blood cell flocculant, such as particles of the red blood cell flocculant polyDADMAC.
The canister may further provide for a bottom having a cone-like configuration, the cone-like configuration having a sloping sides 3 gradually increasing in with to the base2 of the canister.
The red blood cell flocculant may be provided on the inside of the canister by any variety of methods, such as those described herein. Alternatively, the red blood cell flocculant may be provided in a liquid or dry powder form to the canister either at the same time or before adding a fluid of interest such as a surgical fluid obtained from a subject undergoing a surgical procedure) to the canister. Such surgical fluids are typically suspected to contain blood, and therefore red blood cells. Measurement of the sedimentation level of the red blood cells in the fluid in the presence of the red blood cell flocculant, at room temperature (such as in a surgical suite), provides a rapid method for assessing blood volume in a subject's fluid, and thus blood loss, contemporaneously during the surgical procedure.
Table 10—Normal Values for Leukogram Data (Adult Aminals)
The present example describes a computer implemented method for approximating blood volume in a fluid.
Among other things, the computer implemented method provided here does not rely upon or require electronic or photographic assessment of the fluid. However, it is anticipated that the methods and devices may be adapted for use in combination with electronic, photographic and other accessory tools. A QR code (quick response code) is a type of two dimensional (2D) bar code that is used to provide easy access to online information through the digital camera on a smartphone or tablet. The methods described herein may be computer-implemented and performed at least in part by one or more processors. For example, as shown in
The computer device includes a central processing unit (CPU) and a display 2102 upon which information may be displayed. The display 2102 includes the ability to receive inputs from the computer device 2101. The display 2102 interfaces with a CPU of the computer device 2101. The computer device 2101 also has a scanning device 2103 capable of scanning a Quick Response (“QR”) code, such as though the camera of a smart device (iPhone, tablet, etc.). A QR code (quick response code) is a type of two dimensional (2D) bar code that is used to provide access to online information through the digital camera on a smartphone or tablet.
As shown in
Upon receiving the information, the computer implemented system applies the following “algorithm” to determine Blood Volume (Vb) in the fluid 2112:
V
b
=V
m
/Hct×η
The determined Blood Volume (Vb) in in the subject fluid is transmitted back to the User via return electronic transmission to the computer device 2113 and displayed via the GUI 2114.
Generally, one or more processors may be configured to execute the instructions that are stored in memory of the computer device such that, when it executes the instructions, the processor performs aspects of the methods described herein. The instructions may be executed by computer-executable components integrated with the application, applet, host, server, network, web site, communication service, communication interface, hardware/firmware/software elements of a user computer or mobile device, wristband, smartphone, or any combination thereof. The instructions may be stored on memory or other computer-readable medium such as RAMS, ROMs, flash memory, EEPROMs, optical devices (e.g., CD or DVD), hard drives, floppy drives, or any suitable device.
Generally, in one variation, the processor may be configured to receive the information about the type of canister with its corresponding RBC packing ratio (n), the Subject ID and Info, a Hematocrit (Hct) Value, and a Sedimented and/or settled red blood cell (RBC) volume (ml) measure. The processor will then execute a series of steps that upon execution by the computer, determines a volume of blood in a fluid, and provides the information to the user. The processor may additionally or alternatively be configured to perform some or all aspects of any of the variations of the methods described herein. As described above, the one or more processors may be integrated into a computer device such as a mobile phone or tablet. In other variations, the one or more processors may be incorporated into a computing device or system, such as a cloud-based computer system, a mainframe computer system, a grid-computer system, or other suitable computer system.
The QR code may be configured to display one or more of the following types of information about the type of canister with its corresponding RBC packing ratio, the Subject ID and Info, the Hematocrit (Hct) Value (such as an average human adult male or female hematocrit value), the Sedimented RBC volume (ml), and volume of blood in a fluid. The display may be configured to display or otherwise communicate to a user (e.g., doctor, nurse, technician) other information, including but not limited to patient information, images of containers or substrates, etc. The display includes a display screen on a computer device, such as a display screen on a handheld or mobile device, a computer monitor, a television screen, a projector screen, or other suitable display. In some variations, the display may be configured to display a user interface that enables the user to input information, select display options (e.g., font, color, language, etc.) and/or content (e.g., patient information, fluid-related information, alerts, etc.). In these variations, the display may be user-interactive and include a resistive or capacitive touch screen that is responsive to skin, a stylet, or other user contact. In other variations, the display may be user-interactive via a cursor controlled by a mouse, keyboard, or other suitable input device.
The examples set forth above are provided to give those of ordinary skill in the art a complete disclosure and description of how to make and use the embodiments of the methods for prediction of the selected modifications that may be made to a biomolecule of interest, and are not intended to limit the scope of what the inventors regard as the scope of the disclosure. Modifications of the above-described modes for carrying out the disclosure can be used by persons of skill in the art, and are intended to be within the scope of the following claims.
It is to be understood that the disclosure is not limited to particular methods or systems, which can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
A number of embodiments of the disclosure have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the present disclosure. Accordingly, other embodiments are within the scope of the following claims.
The forging examples present a description of various specific aspects of the intended invention, and are not presented to limit the intended invention in any way.
In the forging description, for purposes of explanation, specific numbers, materials and configurations are set forth in order to provide a thorough understanding of the invention. It will be apparent, however, to one having ordinary skill in the art that the invention may be practiced without these specific details. In some instances, well-known features may be omitted or simplified so as not to obscure the present invention. Furthermore, reference in the specification to phrases such as “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment of the invention. The appearances of phrases such as “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment.
As used herein, “logic” is an alternative or additional processing resource to perform a particular action and/or function, etc., described herein, which includes hardware, e.g., various forms of transistor logic, application specific integrated circuits (ASICs), etc., as opposed to computer executable instructions, e.g., software firmware, etc., stored in memory and executable by a processor.
As used herein, “a” or “a number of” something can refer to one or more such things. For example, “a number of widgets” can refer to one or more widgets.
In the present disclosure, reference is made to the accompanying drawings that form a part hereof, and in which is shown by way of illustration how a number of examples of the disclosure can be practiced. These examples are described in sufficient detail to enable those of ordinary skill in the art to practice the examples of this disclosure, and it is to be understood that other examples can be used and that process, electrical, and/or structural changes can be made without departing from the scope of the present disclosure.
The figures herein follow a numbering convention in which the first digit corresponds to the drawing figure number and the remaining digits identify an element or component in the drawing. Elements shown in the various figures herein can be added, exchanged, and/or eliminated so as to provide a number of additional examples of the present disclosure. In addition, the proportion and the relative scale of the elements provided in the figures are intended to illustrate the examples of the present disclosure, and should not be taken in a limiting sense.
The specification examples provide a description of the applications and use of the system and method of the present disclosure. Since many examples can be made without departing from the spirit and scope of the system and method of the present disclosure, this specification sets forth some of the many possible example configurations and implementations.
The foregoing description, for purposes of explanation, used specific nomenclature to provide a thorough understanding of the invention. However, it will be apparent to one skilled in the art that specific details are not required in order to practice the invention. Thus, the foregoing descriptions of specific embodiments of the invention are presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms disclosed, as many modifications and variations are possible in view of the above teachings. The embodiments were chosen and described in order to best explain the principles of the invention and its practical applications, they thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated. It is intended that the following claims and their equivalents define the scope of the invention.
The following references are incorporated herein in their entirety.
The present application is a continuation-in-part application of U.S. patent application Ser. No. 16/577,708, filed Aug. 30, 2019, which was a divisional of U.S. patent application Ser. No. 15/868,983, filed Jan. 11, 2018, which issued as U.S. Pat. No. 10,401,347 on Sep. 3, 2019, which claimed priority to U.S. Provisional Patent Application No. 62/445,067, filed Jan. 11, 2017, all of which are incorporated herein in their entirety.
| Number | Date | Country | |
|---|---|---|---|
| 62445067 | Jan 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15868983 | Jan 2018 | US |
| Child | 16557708 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16557708 | Aug 2019 | US |
| Child | 17877765 | US |
